First-Line Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Landscape and Future Progress

Lung cancer is one of the most common cancers and the leading cause of cancer-related deaths worldwide. Most of these patients with non-small cell lung cancer (NSCLC) present with the advanced stage of the disease at the time of diagnosis, and thus decrease the 5-year survival rate to about 5%. Immu...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Pharmacol
Huvudupphovsmän: Huang, Zhangfeng, Su, Wenhao, Lu, Tong, Wang, Yuanyong, Dong, Yanting, Qin, Yi, Liu, Dahai, Sun, Lili, Jiao, Wenjie
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2020
Ämnen:
Pharmacology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7577011/
https://ncbi.nlm.nih.gov/pubmed/33117170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.578091
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk